The results in the CD161 blockade implicate that CD161 binding to the LLT1 ligand on infected macrophages can bring proximity between CD4+CD161+T cells and target cells for immune activation and subsequent anti-TB cytokine actions. The gene discussed is CLEC2D; the disease is tuberculosis.